688520 神州细胞
已收盘 07-18 15:00:01
资讯
新帖
简况
生物制品行业盘中拉升,科兴制药涨8.38%
市场透视 · 07-17 02:01
生物制品行业盘中拉升,科兴制药涨8.38%
神州细胞涨5.05% 政策利好与机构资金流入推动股价上行
智选洞察 · 07-17 01:43
神州细胞涨5.05% 政策利好与机构资金流入推动股价上行
单抗概念盘中拉升,华东医药涨3.84%
市场透视 · 07-16
单抗概念盘中拉升,华东医药涨3.84%
医药主题基金首批二季报出炉!这只产品规模环比增30倍
北京商报官方账号 · 07-14
医药主题基金首批二季报出炉!这只产品规模环比增30倍
医药生物行业周报:关注创新投资主线
东方财富证券 · 07-06
医药生物行业周报:关注创新投资主线
股价翻倍!神州细胞的BD盲盒
药事纵横 · 07-06
股价翻倍!神州细胞的BD盲盒
龙虎榜 | 机构狂买神州细胞,西测测试惨遭多游资“一日游”!
新浪财经 · 07-04
龙虎榜 | 机构狂买神州细胞,西测测试惨遭多游资“一日游”!
神州细胞:股票交易异常波动
南方财经网 · 07-04
神州细胞:股票交易异常波动
7月4日神州细胞涨16.46%,招商核心优选股票A基金重仓该股
证券之星 · 07-04
7月4日神州细胞涨16.46%,招商核心优选股票A基金重仓该股
创新药板块逆势上行,机构称创新药为核心投资主线
每日经济新闻 · 07-04
创新药板块逆势上行,机构称创新药为核心投资主线
百度概念盘中拉升,数据港涨停
市场透视 · 07-04
百度概念盘中拉升,数据港涨停
7月3日神州细胞(688520)龙虎榜数据:机构净买入1.19亿元,北向资金净买入6562.05万元
证券之星 · 07-03
7月3日神州细胞(688520)龙虎榜数据:机构净买入1.19亿元,北向资金净买入6562.05万元
神州细胞涨19.99%,国金证券二个月前给出“买入”评级
证券之星 · 07-03
神州细胞涨19.99%,国金证券二个月前给出“买入”评级
神州细胞:公司目前不存在任何产品管线BD应披露而未披露的重大交易信息
证券之星 · 07-03
神州细胞:公司目前不存在任何产品管线BD应披露而未披露的重大交易信息
突发核弹利好!A股原地起飞!这个板块猛猛涨!
萝卜投研 · 07-03
突发核弹利好!A股原地起飞!这个板块猛猛涨!
龙头药企再传重磅,国内首只药ETF(562050)拉涨1%!神州细胞飙升18%,长春高新涨超7%
市场资讯 · 07-03
龙头药企再传重磅,国内首只药ETF(562050)拉涨1%!神州细胞飙升18%,长春高新涨超7%
单抗概念盘中拉升,神州细胞涨16.49%
市场透视 · 07-03
单抗概念盘中拉升,神州细胞涨16.49%
肿瘤治疗概念盘中拉升,神州细胞涨14.43%
市场透视 · 07-03
肿瘤治疗概念盘中拉升,神州细胞涨14.43%
神州细胞:神州安元、神州安恒等股东合计减持0.42%公司股份
格隆汇 · 07-02
神州细胞:神州安元、神州安恒等股东合计减持0.42%公司股份
中国创新药能否持续让世界买单?券商分析师最新观点
券商中国 · 06-30
中国创新药能否持续让世界买单?券商分析师最新观点
加载更多
公司概况
公司名称:
北京神州细胞生物技术集团股份公司
所属行业:
医药制造业
上市日期:
2020-06-22
主营业务:
北京神州细胞生物技术集团股份公司的主营业务是恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。公司的主要产品是SCT800(安佳因®)、SCT400(安平希®)、SCT630(安佳润®)、SCT510(安贝珠®)、SCTV01、SCT-I10A(安佑平®)、SCT1000。2024年初,公司首次荣获北京市药监局“2023年度不良反应监测工作表现突出单位”称号。
发行价格:
25.64
{"stockData":{"symbol":"688520","market":"SH","secType":"STK","nameCN":"神州细胞","latestPrice":84.95,"timestamp":1752822001000,"preClose":85.63,"halted":0,"volume":11182658,"delay":0,"changeRate":-0.0079,"floatShares":445000000,"shares":445000000,"eps":0.228,"marketStatus":"已收盘","change":-0.68,"latestTime":"07-18 15:00:01","open":84,"high":86.3,"low":81.66,"amount":938000000,"amplitude":0.0542,"askPrice":84.95,"askSize":13,"bidPrice":84.94,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.228,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":5,"adr":0,"adjPreClose":85.63,"symbolType":"stock_kcb","openAndCloseTimeList":[[1752802200000,1752809400000],[1752814800000,1752822000000]],"highLimit":94.19,"lowLimit":77.07,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":445335714,"isCdr":false,"pbRate":-93.48,"roa":"--","peRate":372.587719,"roe":"36.86%","epsLYR":0.24,"committee":0.305913,"marketValue":37831000000,"turnoverRate":0.0251,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-07-21。","afterMarket":{"amount":63542.6,"volume":748,"close":84.95,"buyVolume":0,"sellVolume":752,"time":1752824038022,"indexStatus":"已收盘 07-18 15:30:00","preClose":85.63},"floatMarketCap":37831000000},"requestUrl":"/m/hq/s/688520","defaultTab":"news","newsList":[{"id":"2552174242","title":"生物制品行业盘中拉升,科兴制药涨8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174242?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:01","pubTimestamp":1752717679,"startTime":"0","endTime":"0","summary":"07月17日,生物制品行业盘中拉升,截至10点01分,生物制品行业整体指数上涨1.00%,报6509.740点。从个股上来看,该行业的成分股中,科兴制药涨8.38%,神州细胞、智翔金泰-U2只股涨幅超过5%。从资金上来看,截止发稿,生物制品行业主力净流入为-4252.64万,其中神州细胞受到资金热捧,主力净流入6285.20万;拉长时间线来看,该板块近20日主力资金净流入-25.70亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710011997a9217f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4e7834c15c47c74e9bfd4d734ca81974","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710011997a9217f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","688520","BK0239"],"gpt_icon":0},{"id":"2552742731","title":"神州细胞涨5.05% 政策利好与机构资金流入推动股价上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2552742731","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552742731?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:43","pubTimestamp":1752716632,"startTime":"0","endTime":"0","summary":"神州细胞股价今日大幅上涨,截至09点43分,最新价为77.95元/股,涨幅达5.05%。政策博弈与估值兑现共振近期神州细胞股价波动受多重短期因素影响。7月1日国家医保局创新药支持政策落地后,生物制品板块单日上涨1.67%,机构资金连续三日净流入超4700万元。但随后公司股东减持185.79万股,叠加创业板指波动超1%,引发单日股价回调2.77%。创新管线与商业化验证并重长期来看,神州细胞的核心竞争力取决于产品管线的研发进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717094354a44fcd8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717094354a44fcd8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2551115992","title":"单抗概念盘中拉升,华东医药涨3.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551115992?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:35","pubTimestamp":1752629750,"startTime":"0","endTime":"0","summary":"07月16日,单抗概念盘中拉升,截至09点35分,单抗概念整体指数上涨0.55%,报2514.370点。从个股上来看,该概念的成分股中,华东医药涨3.84%,神州细胞、康弘药业、丽珠集团涨幅居前。从资金上来看,截止发稿,单抗概念概念主力净流入为1.25亿,其中恒瑞医药受到资金热捧,主力净流入4251.13万;拉长时间线来看,该板块近20日主力资金净流入6.59亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093550a6ac3693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093550a6ac3693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000963","BK0196","LU1969619763.USD","LU2328871848.SGD","BK0188","BK0183","600276","BK0187","688520","BK0239","BK0209","BK0175","BK0132"],"gpt_icon":0},{"id":"2551188325","title":"医药主题基金首批二季报出炉!这只产品规模环比增30倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188325","media":"北京商报官方账号","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551188325?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:40","pubTimestamp":1752489611,"startTime":"0","endTime":"0","summary":"公募基金二季报陆续披露中。就在前几日,长城基金也披露了旗下4只医药主题基金二季报。从规模变动来看,5只医药主题基金环比均有不同幅度的增长,其中长城医药产业精选混合型发起式的最新规模更大涨超30倍。公开资料显示,截至7月14日,已有永赢医药健康股票、长城医药产业精选混合型发起式、长城医药科技六个月持有期混合、长城医疗保健混合、长城大健康混合合计5只医药健康相关主题基金发布2025年二季报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714184621a6a89973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714184621a6a89973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688192","688068","BK0239","603590","688520","688382","688331","000121.SH"],"gpt_icon":0},{"id":"2549330929","title":"医药生物行业周报:关注创新投资主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2549330929","media":"东方财富证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549330929?lang=zh_cn&edition=full","pubTime":"2025-07-07 00:00","pubTimestamp":1751817600,"startTime":"0","endTime":"0","summary":"近日,国家医保局、国家卫生健康委印发《支持创新药高质量发展的若干措施》,对创新药研发、准入、入院使用和多元支付进行全链条支持。国家医保局发布《2025 年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》,首次在正式系统引入“商保创新药目录”概念,作为基本医保目录的重要补充路径。重磅政策引燃了医药板块行情,本周医药生物指数上涨3.64%,行业涨跌幅排名第4。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707115121a69a1a94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707115121a69a1a94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239","603716","163118","688180","000808.SH","688091","688068"],"gpt_icon":0},{"id":"2549284803","title":"股价翻倍!神州细胞的BD盲盒","url":"https://stock-news.laohu8.com/highlight/detail?id=2549284803","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549284803?lang=zh_cn&edition=full","pubTime":"2025-07-06 08:03","pubTimestamp":1751760213,"startTime":"0","endTime":"0","summary":"随着石药、先声、荣昌等接连的BD披露,出海大浪潮正式开启。国内创新药BD也从打明牌正式到拆盲盒阶段。目前神州细胞SCTB14的BD价值核心在于\"肺癌适应症进度+差异化结构\"的双重稀缺性。对标三生制药,神州细胞的PD-1/VEGF双抗对外存在授权预期,近期股价在一个月左右翻倍。在地区及联盟集采降价的情况下,神州细胞仍能借助灵活有效的市场策略,加强拓展市场份额,确保营收增长稳定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706080549a730e58e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706080549a730e58e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2548939917","title":"龙虎榜 | 机构狂买神州细胞,西测测试惨遭多游资“一日游”!","url":"https://stock-news.laohu8.com/highlight/detail?id=2548939917","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548939917?lang=zh_cn&edition=full","pubTime":"2025-07-04 21:07","pubTimestamp":1751634466,"startTime":"0","endTime":"0","summary":"全天成交1.45万亿元,较前一交易日增量1210亿元,全市场超4100股下跌。此外,雪迪龙、好上好、兴业股份等人气股跌停。龙虎榜中涉及机构专用席位的个股中,当日净买入额前三为神州细胞、西测测试、隆扬电子,分别为1.56亿元、6863.18万元、2119.07万元。龙虎榜数据显示,机构合计净买入6863.18万元。龙虎榜中,涉及沪股通专用席位的个股有4只,热景生物的沪股通专用席位净卖额最大,净卖出4540.09万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507042122039799f6ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507042122039799f6ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0221","688520","BK0239","301306"],"gpt_icon":0},{"id":"2548364616","title":"神州细胞:股票交易异常波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2548364616","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548364616?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:19","pubTimestamp":1751620740,"startTime":"0","endTime":"0","summary":"南财智讯7月4日电,神州细胞公告,公司股票在2025年7月2日至7月4日连续三个交易日内收盘价格涨幅偏离值累计达到30%,构成股票交易异常波动。经公司自查,生产经营情况正常,市场环境、行业政策无重大调整,产品研发及商业化正常推进,内部生产经营秩序正常。公司及控股股东、实际控制人不存在应披露而未披露的重大信息,也不存在处于筹划阶段的重大事项。未发现近期公共媒体报道了可能或已经对公司股票交易价格产生重大影响的未公开重大信息。公司提醒投资者注意二级市场交易风险。(文章来源:南方财经网)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041724319799b98b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041724319799b98b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2548365864","title":"7月4日神州细胞涨16.46%,招商核心优选股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548365864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548365864?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:23","pubTimestamp":1751617434,"startTime":"0","endTime":"0","summary":"证券之星消息,7月4日神州细胞涨16.46%创60日新高,收盘报85.41元,换手率4.53%,成交量20.17万手,成交额16.3亿元。重仓神州细胞的公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级4家;过去90天内机构目标均价为48.94。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为招商基金的招商核心优选股票A。该公募基金现任基金经理为张磊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400025486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2548330540","title":"创新药板块逆势上行,机构称创新药为核心投资主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2548330540","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548330540?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:29","pubTimestamp":1751596152,"startTime":"0","endTime":"0","summary":"7月4日早盘,A股整体小幅回落,医药板块逆势上行,科创医药ETF基金涨幅超0.5%。公开信息显示,科创医药ETF基金跟踪上证科创板生物医药指数,囊括科创板中创新药、国产高端医疗设备、生命科学与生物技术等领域的专精特新公司。伴随政策对创新药保驾护航、创新药获批上市井喷、出海以及国产替代,医药行业有望迎来机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103134a4ce73ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103134a4ce73ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","688520","159992","688331","688505","688091","688076","BK0239"],"gpt_icon":0},{"id":"2548150332","title":"百度概念盘中拉升,数据港涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2548150332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548150332?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:49","pubTimestamp":1751593778,"startTime":"0","endTime":"0","summary":"07月04日,百度概念盘中拉升,截至09点49分,百度概念整体指数上涨0.50%,报1628.380点。从个股上来看,该概念的成分股中,数据港涨停,神州细胞、协鑫能科等5只股涨幅超过5%。从资金上来看,截止发稿,百度概念概念主力净流入为1.43亿,其中数据港受到资金热捧,主力净流入3.83亿;拉长时间线来看,该板块近20日主力资金净流入-327.96亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094938a72db68f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094938a72db68f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4587","BK4612","BIDU","BK4543","LU0287142896.SGD","BK4552","BK4531","LU1115378108.SGD","BK4504","BK4585","LU0640798160.USD","BK4588","LU0173614495.USD","BK4579","BK4548","LU0359202008.SGD","BK4574","LU0359201612.USD","IE00B0JY6N72.USD","BK4077","BK4602","688520","BK4514","BK4535","LU1023057109.AUD","BK4526","BK4614"],"gpt_icon":0},{"id":"2548720708","title":"7月3日神州细胞(688520)龙虎榜数据:机构净买入1.19亿元,北向资金净买入6562.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548720708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548720708?lang=zh_cn&edition=full","pubTime":"2025-07-03 17:17","pubTimestamp":1751534272,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月3日公布的交易公开信息显示,神州细胞因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月3日收盘,神州细胞报收于73.34元,上涨19.99%,涨停,换手率2.85%,成交量12.68万手,成交额8.93亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1.19亿元,北向资金合计净买入6562.05万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300027910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2548879310","title":"神州细胞涨19.99%,国金证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548879310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548879310?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:28","pubTimestamp":1751531282,"startTime":"0","endTime":"0","summary":"今日神州细胞(688520)涨19.99%,收盘报73.34元。2025年4月28日,国金证券研究员赵海春,袁维发布了对神州细胞的研报《八因子强劲,盈利转正;管线丰富,发力可期》,该研报对神州细胞给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为42.1%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的何子瑜、邹朋、郑航慈。神州细胞(688520)个股概况:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300026145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520"],"gpt_icon":0},{"id":"2548787304","title":"神州细胞:公司目前不存在任何产品管线BD应披露而未披露的重大交易信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2548787304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548787304?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:36","pubTimestamp":1751528206,"startTime":"0","endTime":"0","summary":"证券之星消息,神州细胞07月03日在投资者关系平台上答复投资者关心的问题。公司严格遵守信息披露要求,关于公司产品及业务的任何进展,请以公司正式披露信息为准。公司目前不存在任何产品管线BD应披露而未披露的重大交易信息。公司提请投资人,切勿轻信未经证实的消息参与短期投机性的交易,重视投资风险,审慎做出长期投资决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300020071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2548827284","title":"突发核弹利好!A股原地起飞!这个板块猛猛涨!","url":"https://stock-news.laohu8.com/highlight/detail?id=2548827284","media":"萝卜投研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548827284?lang=zh_cn&edition=full","pubTime":"2025-07-03 14:30","pubTimestamp":1751524235,"startTime":"0","endTime":"0","summary":"今天消费电子概念反弹,同花顺果指数领涨,工业富联、鹏鼎控股、蓝思科技等个股大涨。另外,AI PC、AI手机等板块也上涨。按照此流程,2026年下半年折叠iPhone将会上市。EDA作为芯片设计的核心工具,此前受限于出口管制,中国本土芯片设计企业面临“卡脖子”困境。创新药板块上涨,带动医药股集体走强,生物制品、生物医疗、中药等板块涨幅居前。预计第三季度 A 股指数仍将在 924 行情以来的宽幅震荡区间内,市场风格或将继续轮动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703143257a4cca88b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703143257a4cca88b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399300","BK0239","688520","159982","601138"],"gpt_icon":0},{"id":"2548828521","title":"龙头药企再传重磅,国内首只药ETF(562050)拉涨1%!神州细胞飙升18%,长春高新涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548828521","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548828521?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:20","pubTimestamp":1751509200,"startTime":"0","endTime":"0","summary":"7月3日早盘,制药板块再度活跃,聚焦龙头药企的药ETF拉升逾1%。成份股方面,创新药概念股再度领涨,神州细胞飙升逾18%,长春高新涨超7%。此外,中药龙头以岭药业同步大涨近6%。 公开资料显示,药ETF是国内首只跟踪中证制药指数的ETF,纯粹配置“化学药+生物药品+中药”三大领域龙头制药企业,不含医疗和CXO。聚焦制药板块机会,认准国内首只药ETF,既有创新药驱动高成长,又有中药降低指数波动,并且完全不含医疗和CXO。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-07-03/doc-infeeerq1729933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","562050","BK0075","BK0188","BK0046","000661","BK0239","688520","BK0057"],"gpt_icon":0},{"id":"2548840413","title":"单抗概念盘中拉升,神州细胞涨16.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548840413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548840413?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:00","pubTimestamp":1751508017,"startTime":"0","endTime":"0","summary":"07月03日,单抗概念盘中拉升,截至10点00分,单抗概念整体指数上涨2.07%,报2376.640点。从个股上来看,该概念的成分股中,神州细胞涨16.49%,长春高新、舒泰神等3只股涨幅超过5%。从资金上来看,截止发稿,单抗概念概念主力净流入为1.97亿,其中长春高新受到资金热捧,主力净流入8311.61万;拉长时间线来看,该板块近20日主力资金净流入-50.66亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031000179534a1f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031000179534a1f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2548384729","title":"肿瘤治疗概念盘中拉升,神州细胞涨14.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548384729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548384729?lang=zh_cn&edition=full","pubTime":"2025-07-03 09:50","pubTimestamp":1751507444,"startTime":"0","endTime":"0","summary":"07月03日,肿瘤治疗概念盘中拉升,截至09点50分,肿瘤治疗概念整体指数上涨1.01%,报1515.370点。从个股上来看,该概念的成分股中,神州细胞涨14.43%,微芯生物涨幅超过5%。从资金上来看,截止发稿,肿瘤治疗概念主力净流入为-2853.67万,其中以岭药业受到资金热捧,主力净流入4240.55万;拉长时间线来看,该板块近20日主力资金净流入-110.96亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095044a72b9893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095044a72b9893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2548899723","title":"神州细胞:神州安元、神州安恒等股东合计减持0.42%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2548899723","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548899723?lang=zh_cn&edition=full","pubTime":"2025-07-02 19:37","pubTimestamp":1751456263,"startTime":"0","endTime":"0","summary":"格隆汇7月2日丨神州细胞(688520.SH)公布,公司于2025年7月2日收到神州安元、神州安恒、神州安隆、神州安成、神州安干及神州安弘出具的《关于股份减持结果的告知函》,神州安元、神州安恒、神州安隆、神州安成、神州安干及神州安弘自2025年6月30日至2025年7月2日通过集中竞价交易方式合计减持公司股份1,857,915股,占公司总股本的0.42%,公司控股股东、实际控制人未参与本次减持。本次减持计划已实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702193753979738af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702193753979738af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单?券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计,2025年1—5月,中国创新药企对外授权交易总金额已达455亿美元,超过2024年上半年的交易总额,创新药出海授权交易大爆发。亮眼数据的背后,是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力,正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期,年内大涨明显的创新药企业荣昌生物股价近期大幅回调,从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","688177","688181","603087","600535","600267","603567","603259","600998","600332","601089","600645","603367","600080","603716","600867","688513","601607","600216","603127","688278","600513","603590","BK0239","600774","688488","688336","06160","603456","688506","600682","600079","600200","600056","688136","688202","688198","603998","688235","688131","688073","688117","600062","688166","688331","600380","600851","600351","605199","688317","688068","688091","688505","688520","600789","688222","688163","688189","688356","603229","603707","600572","600881","600422","600420","600521","600721","600196","688321","159992","600276","688319","600222","600557"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752961150480,"stockEarnings":[{"period":"1week","weight":0.148},{"period":"1month","weight":0.867},{"period":"3month","weight":1.2397},{"period":"6month","weight":1.4552},{"period":"1year","weight":1.1085},{"period":"ytd","weight":1.3447}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.043},{"period":"3month","weight":0.0787},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.1872},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京神州细胞生物技术集团股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11178人(较上一季度增加8.43%)","perCapita":"39840股","listingDate":"2020-06-22","address":"北京市大兴区北京经济技术开发区科创七街31号院5号楼307","registeredCapital":"44533万元","survey":" 北京神州细胞生物技术集团股份公司的主营业务是恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。公司的主要产品是SCT800(安佳因®)、SCT400(安平希®)、SCT630(安佳润®)、SCT510(安贝珠®)、SCTV01、SCT-I10A(安佑平®)、SCT1000。2024年初,公司首次荣获北京市药监局“2023年度不良反应监测工作表现突出单位”称号。","listedPrice":25.64},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"神州细胞,688520,神州细胞股票,神州细胞股票老虎,神州细胞股票老虎国际,神州细胞行情,神州细胞股票行情,神州细胞股价,神州细胞股市,神州细胞股票价格,神州细胞股票交易,神州细胞股票购买,神州细胞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}